Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 37 entries
Sorted by: Best Match Show Resources per page
Systematic review of relaxation interventions for pain

interventions

Kwekkeboom KL.
GSID: vBx3J82oE8UJ
KL Kwekkeboom, E Gretarsdottir - Journal of nursing …, 2006 - Wiley Online Library

… Findings: Researchers reported support for relaxation interventions in 8 of the 15 studies … which limited the ability to draw conclusions about interventions. Further research is needed to confirm … that might influence response to relaxation interventions. These...

Cite
Kwekkeboom, K. L., & Gretarsdottir, E. (2006). Systematic review of relaxation interventions for pain. Journal of nursing scholarship, 38(3), 269-277.
Kwekkeboom, Kristine L., and Elfa Gretarsdottir. "Systematic review of relaxation interventions for pain." Journal of nursing scholarship 38.3 (2006): 269-277.
Copy Download .nbib Format: MLA
Protective Cytomegalovirus (CMV)-Specific T-Cell Immunity Is Frequent in Kidney Transplant Patients without Serum Anti-CMV Antibodies.

Frontiers in immunology

Litjens NHR, Huang L, Dedeoglu B, Meijers RWJ, Kwekkeboom J, Betjes MGH.
PMID: 28955345
Front Immunol. 2017 Sep 12;8:1137. doi: 10.3389/fimmu.2017.01137. eCollection 2017.

The absence of anti-cytomegalovirus (CMV) immunoglobulin G (IgG) is used to classify pretransplant patients as naïve for CMV infection (CMV

Cite
Litjens NHR, Huang L, Dedeoglu B, et al. Protective Cytomegalovirus (CMV)-Specific T-Cell Immunity Is Frequent in Kidney Transplant Patients without Serum Anti-CMV Antibodies. Front Immunol. 2017;8:1137doi: 10.3389/fimmu.2017.01137.
Litjens, N. H. R., Huang, L., Dedeoglu, B., Meijers, R. W. J., Kwekkeboom, J., & Betjes, M. G. H. (2017). Protective Cytomegalovirus (CMV)-Specific T-Cell Immunity Is Frequent in Kidney Transplant Patients without Serum Anti-CMV Antibodies. Frontiers in immunology, 81137. https://doi.org/10.3389/fimmu.2017.01137
Litjens, Nicolle H R, et al. "Protective Cytomegalovirus (CMV)-Specific T-Cell Immunity Is Frequent in Kidney Transplant Patients without Serum Anti-CMV Antibodies." Frontiers in immunology vol. 8 (2017): 1137. doi: https://doi.org/10.3389/fimmu.2017.01137
Litjens NHR, Huang L, Dedeoglu B, Meijers RWJ, Kwekkeboom J, Betjes MGH. Protective Cytomegalovirus (CMV)-Specific T-Cell Immunity Is Frequent in Kidney Transplant Patients without Serum Anti-CMV Antibodies. Front Immunol. 2017 Sep 12;8:1137. doi: 10.3389/fimmu.2017.01137. eCollection 2017. PMID: 28955345; PMCID: PMC5600906.
Copy Download .nbib Format: NLM
Immune suppressive checkpoint interactions in the tumour microenvironment of primary liver cancers.

British journal of cancer

Zhou G, Boor PPC, Bruno MJ, Sprengers D, Kwekkeboom J.
PMID: 34400801
Br J Cancer. 2021 Aug 16; doi: 10.1038/s41416-021-01453-3. Epub 2021 Aug 16.

Liver cancer is one of the most prevalent cancers, and the third most common cause of cancer-related mortality worldwide. The therapeutic options for the main types of primary liver cancer-hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA)-are very limited. HCC and...

Cite
Zhou G, Boor PPC, Bruno MJ, et al. Immune suppressive checkpoint interactions in the tumour microenvironment of primary liver cancers. Br J Cancer. 2021;doi: 10.1038/s41416-021-01453-3.
Zhou, G., Boor, P. P. C., Bruno, M. J., Sprengers, D., & Kwekkeboom, J. (2021). Immune suppressive checkpoint interactions in the tumour microenvironment of primary liver cancers. British journal of cancer, . https://doi.org/10.1038/s41416-021-01453-3
Zhou, Guoying, et al. "Immune suppressive checkpoint interactions in the tumour microenvironment of primary liver cancers." British journal of cancer vol. (2021). doi: https://doi.org/10.1038/s41416-021-01453-3
Zhou G, Boor PPC, Bruno MJ, Sprengers D, Kwekkeboom J. Immune suppressive checkpoint interactions in the tumour microenvironment of primary liver cancers. Br J Cancer. 2021 Aug 16; doi: 10.1038/s41416-021-01453-3. Epub 2021 Aug 16. PMID: 34400801.
Copy Download .nbib Format: NLM
TIGIT and PD1 Co-blockade Restores ex vivo Functions of Human Tumor-Infiltrating CD8.

Cellular and molecular gastroenterology and hepatology

Ge Z, Zhou G, Campos Carrascosa L, Gausvik E, Boor PPC, Noordam L, Doukas M, Polak WG, Terkivatan T, Pan Q, Takkenberg RB, Verheij J, Erdmann JI, IJzermans JNM, Peppelenbosch MP, Kraan J, Kwekkeboom J, Sprengers D.
PMID: 33781741
Cell Mol Gastroenterol Hepatol. 2021;12(2):443-464. doi: 10.1016/j.jcmgh.2021.03.003. Epub 2021 Mar 27.

BACKGROUND & AIMS: TIGIT is a co-inhibitory receptor, and its suitability as a target for cancer immunotherapy in HCC is unknown. PD1 blockade is clinically effective in about 20% of advanced HCC patients. Here we aim to determine whether...

Cite
Ge Z, Zhou G, Campos Carrascosa L, et al. TIGIT and PD1 Co-blockade Restores ex vivo Functions of Human Tumor-Infiltrating CD8. Cell Mol Gastroenterol Hepatol. 2021;12(2):443-464doi: 10.1016/j.jcmgh.2021.03.003.
Ge, Z., Zhou, G., Campos Carrascosa, L., Gausvik, E., Boor, P. P. C., Noordam, L., Doukas, M., Polak, W. G., Terkivatan, T., Pan, Q., Takkenberg, R. B., Verheij, J., Erdmann, J. I., IJzermans, J. N. M., Peppelenbosch, M. P., Kraan, J., Kwekkeboom, J., & Sprengers, D. (2021). TIGIT and PD1 Co-blockade Restores ex vivo Functions of Human Tumor-Infiltrating CD8. Cellular and molecular gastroenterology and hepatology, 12(2), 443-464. https://doi.org/10.1016/j.jcmgh.2021.03.003
Ge, Zhouhong, et al. "TIGIT and PD1 Co-blockade Restores ex vivo Functions of Human Tumor-Infiltrating CD8." Cellular and molecular gastroenterology and hepatology vol. 12,2 (2021): 443-464. doi: https://doi.org/10.1016/j.jcmgh.2021.03.003
Ge Z, Zhou G, Campos Carrascosa L, Gausvik E, Boor PPC, Noordam L, Doukas M, Polak WG, Terkivatan T, Pan Q, Takkenberg RB, Verheij J, Erdmann JI, IJzermans JNM, Peppelenbosch MP, Kraan J, Kwekkeboom J, Sprengers D. TIGIT and PD1 Co-blockade Restores ex vivo Functions of Human Tumor-Infiltrating CD8. Cell Mol Gastroenterol Hepatol. 2021;12(2):443-464. doi: 10.1016/j.jcmgh.2021.03.003. Epub 2021 Mar 27. PMID: 33781741; PMCID: PMC8255944.
Copy Download .nbib Format: NLM
Intersectionality in informal care research: a scoping review.

Scandinavian journal of public health

Hengelaar AH, Wittenberg Y, Kwekkeboom R, Van Hartingsveldt M, Verdonk P.
PMID: 34232094
Scand J Public Health. 2021 Jul 07;14034948211027816. doi: 10.1177/14034948211027816. Epub 2021 Jul 07.

No abstract available.

Cite
Hengelaar AH, Wittenberg Y, Kwekkeboom R, et al. Intersectionality in informal care research: a scoping review. Scand J Public Health. 2021;14034948211027816doi: 10.1177/14034948211027816.
Hengelaar, A. H., Wittenberg, Y., Kwekkeboom, R., Van Hartingsveldt, M., & Verdonk, P. (2021). Intersectionality in informal care research: a scoping review. Scandinavian journal of public health, 14034948211027816. https://doi.org/10.1177/14034948211027816
Hengelaar, Aldiene H, et al. "Intersectionality in informal care research: a scoping review." Scandinavian journal of public health vol. (2021): 14034948211027816. doi: https://doi.org/10.1177/14034948211027816
Hengelaar AH, Wittenberg Y, Kwekkeboom R, Van Hartingsveldt M, Verdonk P. Intersectionality in informal care research: a scoping review. Scand J Public Health. 2021 Jul 07;14034948211027816. doi: 10.1177/14034948211027816. Epub 2021 Jul 07. PMID: 34232094.
Copy Download .nbib Format: NLM
Camrelizumab-targeting a novel PD-1 epitope to treat hepatocellular carcinoma.

Annals of translational medicine

Rakké YS, Sprengers D, Kwekkeboom J, IJzermans JNM.
PMID: 33437813
Ann Transl Med. 2020 Dec;8(23):1614. doi: 10.21037/atm-2020-115.

No abstract available.

Cite
Rakké YS, Sprengers D, Kwekkeboom J, et al. Camrelizumab-targeting a novel PD-1 epitope to treat hepatocellular carcinoma. Ann Transl Med. 2020;8(23):1614doi: 10.21037/atm-2020-115.
Rakké, Y. S., Sprengers, D., Kwekkeboom, J., & IJzermans, J. N. M. (2020). Camrelizumab-targeting a novel PD-1 epitope to treat hepatocellular carcinoma. Annals of translational medicine, 8(23), 1614. https://doi.org/10.21037/atm-2020-115
Rakké, Yannick Sebastiaan, et al. "Camrelizumab-targeting a novel PD-1 epitope to treat hepatocellular carcinoma." Annals of translational medicine vol. 8,23 (2020): 1614. doi: https://doi.org/10.21037/atm-2020-115
Rakké YS, Sprengers D, Kwekkeboom J, IJzermans JNM. Camrelizumab-targeting a novel PD-1 epitope to treat hepatocellular carcinoma. Ann Transl Med. 2020 Dec;8(23):1614. doi: 10.21037/atm-2020-115. PMID: 33437813; PMCID: PMC7791240.
Copy Download .nbib Format: NLM
Activated CD4.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Duizendstra AA, de Knegt RJ, Mancham S, Klepper M, Roelen DL, Brand-Schaaf SH, Boor PP, Doukas M, de Man RA, Sprengers D, Peppelenbosch MP, Betjes MGH, Kwekkeboom J, Litjens NHR.
PMID: 34081828
Liver Transpl. 2022 Jan;28(1):98-112. doi: 10.1002/lt.26188. Epub 2021 Jul 21.

Spontaneous operational tolerance to the allograft develops in a proportion of liver transplantation (LT) recipients weaned off immunosuppressive (IS) drugs. Several studies have investigated whether peripheral blood circulating T cells could play a role in the development or identify...

Cite
Duizendstra AA, de Knegt RJ, Mancham S, et al. Activated CD4. Liver Transpl. 2021;28(1):98-112doi: 10.1002/lt.26188.
Duizendstra, A. A., de Knegt, R. J., Mancham, S., Klepper, M., Roelen, D. L., Brand-Schaaf, S. H., Boor, P. P., Doukas, M., de Man, R. A., Sprengers, D., Peppelenbosch, M. P., Betjes, M. G. H., Kwekkeboom, J., & Litjens, N. H. R. (2022). Activated CD4. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 28(1), 98-112. https://doi.org/10.1002/lt.26188
Duizendstra, Aafke A, et al. "Activated CD4." Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society vol. 28,1 (2022): 98-112. doi: https://doi.org/10.1002/lt.26188
Duizendstra AA, de Knegt RJ, Mancham S, Klepper M, Roelen DL, Brand-Schaaf SH, Boor PP, Doukas M, de Man RA, Sprengers D, Peppelenbosch MP, Betjes MGH, Kwekkeboom J, Litjens NHR. Activated CD4. Liver Transpl. 2022 Jan;28(1):98-112. doi: 10.1002/lt.26188. Epub 2021 Jul 21. PMID: 34081828.
Copy Download .nbib Format: NLM
Detection of oncogenic mutations in paired circulating tumor DNA and circulating tumor cells in patients with hepatocellular carcinoma.

Translational oncology

Ge Z, Helmijr JCA, Jansen MPHM, Boor PPC, Noordam L, Peppelenbosch M, Kwekkeboom J, Kraan J, Sprengers D.
PMID: 33915518
Transl Oncol. 2021 Jul;14(7):101073. doi: 10.1016/j.tranon.2021.101073. Epub 2021 Apr 26.

BACKGROUND AND AIMS: Circulating tumor cells (CTCs) or circulating tumor DNA (ctDNA) may be used for diagnostic or prognostic purposes in patients with hepatocellular carcinoma (HCC). We aim to determine whether CTCs or ctDNA are suitable to determine oncogenic...

Cite
Ge Z, Helmijr JCA, Jansen MPHM, et al. Detection of oncogenic mutations in paired circulating tumor DNA and circulating tumor cells in patients with hepatocellular carcinoma. Transl Oncol. 2021;14(7):101073doi: 10.1016/j.tranon.2021.101073.
Ge, Z., Helmijr, J. C. A., Jansen, M. P. H. M., Boor, P. P. C., Noordam, L., Peppelenbosch, M., Kwekkeboom, J., Kraan, J., & Sprengers, D. (2021). Detection of oncogenic mutations in paired circulating tumor DNA and circulating tumor cells in patients with hepatocellular carcinoma. Translational oncology, 14(7), 101073. https://doi.org/10.1016/j.tranon.2021.101073
Ge, Zhouhong, et al. "Detection of oncogenic mutations in paired circulating tumor DNA and circulating tumor cells in patients with hepatocellular carcinoma." Translational oncology vol. 14,7 (2021): 101073. doi: https://doi.org/10.1016/j.tranon.2021.101073
Ge Z, Helmijr JCA, Jansen MPHM, Boor PPC, Noordam L, Peppelenbosch M, Kwekkeboom J, Kraan J, Sprengers D. Detection of oncogenic mutations in paired circulating tumor DNA and circulating tumor cells in patients with hepatocellular carcinoma. Transl Oncol. 2021 Jul;14(7):101073. doi: 10.1016/j.tranon.2021.101073. Epub 2021 Apr 26. PMID: 33915518; PMCID: PMC8100622.
Copy Download .nbib Format: NLM
A Delphic consensus assessment: imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease management.

Endocrine connections

Oberg K, Krenning E, Sundin A, Bodei L, Kidd M, Tesselaar M, Ambrosini V, Baum RP, Kulke M, Pavel M, Cwikla J, Drozdov I, Falconi M, Fazio N, Frilling A, Jensen R, Koopmans K, Korse T, Kwekkeboom D, Maecke H, Paganelli G, Salazar R, Severi S, Strosberg J, Prasad V, Scarpa A, Grossman A, Walenkamp A, Cives M, Virgolini I, Kjaer A, Modlin IM.
PMID: 27582247
Endocr Connect. 2016 Sep;5(5):174-87. doi: 10.1530/EC-16-0043. Epub 2016 Aug 31.

The complexity of the clinical management of neuroendocrine neoplasia (NEN) is exacerbated by limitations in imaging modalities and a paucity of clinically useful biomarkers. Limitations in currently available imaging modalities reflect difficulties in measuring an intrinsically indolent disease, resolution...

Cite
Oberg K, Krenning E, Sundin A, et al. A Delphic consensus assessment: imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease management. Endocr Connect. 2016;5(5):174-87doi: 10.1530/EC-16-0043.
Oberg, K., Krenning, E., Sundin, A., Bodei, L., Kidd, M., Tesselaar, M., Ambrosini, V., Baum, R. P., Kulke, M., Pavel, M., Cwikla, J., Drozdov, I., Falconi, M., Fazio, N., Frilling, A., Jensen, R., Koopmans, K., Korse, T., Kwekkeboom, D., Maecke, H., Paganelli, G., Salazar, R., Severi, S., Strosberg, J., Prasad, V., Scarpa, A., Grossman, A., Walenkamp, A., Cives, M., Virgolini, I., Kjaer, A., & Modlin, I. M. (2016). A Delphic consensus assessment: imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease management. Endocrine connections, 5(5), 174-87. https://doi.org/10.1530/EC-16-0043
Oberg, Kjell, et al. "A Delphic consensus assessment: imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease management." Endocrine connections vol. 5,5 (2016): 174-87. doi: https://doi.org/10.1530/EC-16-0043
Oberg K, Krenning E, Sundin A, Bodei L, Kidd M, Tesselaar M, Ambrosini V, Baum RP, Kulke M, Pavel M, Cwikla J, Drozdov I, Falconi M, Fazio N, Frilling A, Jensen R, Koopmans K, Korse T, Kwekkeboom D, Maecke H, Paganelli G, Salazar R, Severi S, Strosberg J, Prasad V, Scarpa A, Grossman A, Walenkamp A, Cives M, Virgolini I, Kjaer A, Modlin IM. A Delphic consensus assessment: imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease management. Endocr Connect. 2016 Sep;5(5):174-87. doi: 10.1530/EC-16-0043. Epub 2016 Aug 31. PMID: 27582247; PMCID: PMC5045519.
Copy Download .nbib Format: NLM
Cancer-Associated Fibroblasts Provide a Stromal Niche for Liver Cancer Organoids That Confers Trophic Effects and Therapy Resistance.

Cellular and molecular gastroenterology and hepatology

Liu J, Li P, Wang L, Li M, Ge Z, Noordam L, Lieshout R, Verstegen MMA, Ma B, Su J, Yang Q, Zhang R, Zhou G, Carrascosa LC, Sprengers D, IJzermans JNM, Smits R, Kwekkeboom J, van der Laan LJW, Peppelenbosch MP, Pan Q, Cao W.
PMID: 32932015
Cell Mol Gastroenterol Hepatol. 2021;11(2):407-431. doi: 10.1016/j.jcmgh.2020.09.003. Epub 2020 Sep 12.

BACKGROUND & AIMS: Cancer-associated fibroblasts (CAFs) play a key role in the cancer process, but the research progress is hampered by the paucity of preclinical models that are essential for mechanistic dissection of cancer cell-CAF interactions. Here, we aimed...

Cite
Liu J, Li P, Wang L, et al. Cancer-Associated Fibroblasts Provide a Stromal Niche for Liver Cancer Organoids That Confers Trophic Effects and Therapy Resistance. Cell Mol Gastroenterol Hepatol. 2020;11(2):407-431doi: 10.1016/j.jcmgh.2020.09.003.
Liu, J., Li, P., Wang, L., Li, M., Ge, Z., Noordam, L., Lieshout, R., Verstegen, M. M. A., Ma, B., Su, J., Yang, Q., Zhang, R., Zhou, G., Carrascosa, L. C., Sprengers, D., IJzermans, J. N. M., Smits, R., Kwekkeboom, J., van der Laan, L. J. W., Peppelenbosch, M. P., Pan, Q., & Cao, W. (2021). Cancer-Associated Fibroblasts Provide a Stromal Niche for Liver Cancer Organoids That Confers Trophic Effects and Therapy Resistance. Cellular and molecular gastroenterology and hepatology, 11(2), 407-431. https://doi.org/10.1016/j.jcmgh.2020.09.003
Liu, Jiaye, et al. "Cancer-Associated Fibroblasts Provide a Stromal Niche for Liver Cancer Organoids That Confers Trophic Effects and Therapy Resistance." Cellular and molecular gastroenterology and hepatology vol. 11,2 (2021): 407-431. doi: https://doi.org/10.1016/j.jcmgh.2020.09.003
Liu J, Li P, Wang L, Li M, Ge Z, Noordam L, Lieshout R, Verstegen MMA, Ma B, Su J, Yang Q, Zhang R, Zhou G, Carrascosa LC, Sprengers D, IJzermans JNM, Smits R, Kwekkeboom J, van der Laan LJW, Peppelenbosch MP, Pan Q, Cao W. Cancer-Associated Fibroblasts Provide a Stromal Niche for Liver Cancer Organoids That Confers Trophic Effects and Therapy Resistance. Cell Mol Gastroenterol Hepatol. 2021;11(2):407-431. doi: 10.1016/j.jcmgh.2020.09.003. Epub 2020 Sep 12. PMID: 32932015; PMCID: PMC7788239.
Copy Download .nbib Format: NLM
Informal caregivers' views on the division of responsibilities between themselves and professionals: A scoping review.

Health & social care in the community

Wittenberg Y, Kwekkeboom R, Staaks J, Verhoeff A, de Boer A.
PMID: 29250848
Health Soc Care Community. 2018 Jul;26(4):e460-e473. doi: 10.1111/hsc.12529. Epub 2017 Dec 18.

This scoping review focuses on the views of informal caregivers regarding the division of care responsibilities between citizens, governments and professionals and the question of to what extent professionals take these views into account during collaboration with them. In...

Cite
Wittenberg Y, Kwekkeboom R, Staaks J, et al. Informal caregivers' views on the division of responsibilities between themselves and professionals: A scoping review. Health Soc Care Community. 2017;26(4):e460-e473doi: 10.1111/hsc.12529.
Wittenberg, Y., Kwekkeboom, R., Staaks, J., Verhoeff, A., & de Boer, A. (2018). Informal caregivers' views on the division of responsibilities between themselves and professionals: A scoping review. Health & social care in the community, 26(4), e460-e473. https://doi.org/10.1111/hsc.12529
Wittenberg, Yvette, et al. "Informal caregivers' views on the division of responsibilities between themselves and professionals: A scoping review." Health & social care in the community vol. 26,4 (2018): e460-e473. doi: https://doi.org/10.1111/hsc.12529
Wittenberg Y, Kwekkeboom R, Staaks J, Verhoeff A, de Boer A. Informal caregivers' views on the division of responsibilities between themselves and professionals: A scoping review. Health Soc Care Community. 2018 Jul;26(4):e460-e473. doi: 10.1111/hsc.12529. Epub 2017 Dec 18. PMID: 29250848.
Copy Download .nbib Format: NLM
Efficacy of Oral Ginger (Zingiber officinale) for Dysmenorrhea: A Systematic Review and Meta-Analysis.

Evidence-based complementary and alternative medicine : eCAM

Chen CX, Barrett B, Kwekkeboom KL.
PMID: 27274753
Evid Based Complement Alternat Med. 2016;2016:6295737. doi: 10.1155/2016/6295737. Epub 2016 May 05.

This systematic review examines the efficacy of oral ginger for dysmenorrhea. Key biomedical databases and grey literature were searched. We included randomized controlled trials comparing oral ginger against placebo or active treatment in women with dysmenorrhea. Six trials were...

Cite
Chen CX, Barrett B, Kwekkeboom KL. Efficacy of Oral Ginger (Zingiber officinale) for Dysmenorrhea: A Systematic Review and Meta-Analysis. Evid Based Complement Alternat Med. 2016;2016:6295737doi: 10.1155/2016/6295737.
Chen, C. X., Barrett, B., & Kwekkeboom, K. L. (2016). Efficacy of Oral Ginger (Zingiber officinale) for Dysmenorrhea: A Systematic Review and Meta-Analysis. Evidence-based complementary and alternative medicine : eCAM, 20166295737. https://doi.org/10.1155/2016/6295737
Chen, Chen X, et al. "Efficacy of Oral Ginger (Zingiber officinale) for Dysmenorrhea: A Systematic Review and Meta-Analysis." Evidence-based complementary and alternative medicine : eCAM vol. 2016 (2016): 6295737. doi: https://doi.org/10.1155/2016/6295737
Chen CX, Barrett B, Kwekkeboom KL. Efficacy of Oral Ginger (Zingiber officinale) for Dysmenorrhea: A Systematic Review and Meta-Analysis. Evid Based Complement Alternat Med. 2016;2016:6295737. doi: 10.1155/2016/6295737. Epub 2016 May 05. PMID: 27274753; PMCID: PMC4871956.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 37 entries